Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Touat

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Neurology|September 30, 2022
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i>-Mutant Diffuse Gliomas: The <i>IDASPE</i> Prospective StudyAnna Luisa Di Stefano, Lucia Nichelli, Giulia Berzero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced GliomaIngo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
European Journal of Human Genetics : EJHG|April 23, 2023
Lynch syndrome: influence of additional susceptibility variants on cancer riskRoseline Vibert, Jasmine Hasnaoui, Alexandre Perrier, et al.
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trialsCapucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Journal of Neurology|January 2, 2021
SARS-CoV-2 infection in patients with primary central nervous system lymphomaAlice Laurenge, Renata Ursu, Caroline Houillier, et al.
Neuro-Oncology|December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-makingMary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed GlioblastomaMary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Neurology|September 30, 2022
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i>-Mutant Diffuse Gliomas: The <i>IDASPE</i> Prospective StudyAnna Luisa Di Stefano, Lucia Nichelli, Giulia Berzero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced GliomaIngo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
European Journal of Human Genetics : EJHG|April 23, 2023
Lynch syndrome: influence of additional susceptibility variants on cancer riskRoseline Vibert, Jasmine Hasnaoui, Alexandre Perrier, et al.
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trialsCapucine Baldini, Nadia Younan, Eduardo Castanon Alvarez, et al.
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Journal of Neurology|January 2, 2021
SARS-CoV-2 infection in patients with primary central nervous system lymphomaAlice Laurenge, Renata Ursu, Caroline Houillier, et al.
Neuro-Oncology|December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-makingMary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed GlioblastomaMary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Pageof 10